X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs TTK HEALTHCARE - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS TTK HEALTHCARE J.B.CHEMICALS/
TTK HEALTHCARE
 
P/E (TTM) x 17.8 21.4 82.9% View Chart
P/BV x 2.4 7.2 33.4% View Chart
Dividend Yield % 0.2 0.4 40.0%  

Financials

 J.B.CHEMICALS   TTK HEALTHCARE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
TTK HEALTHCARE
Mar-14
J.B.CHEMICALS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs318663 47.9%   
Low Rs200399 50.0%   
Sales per share (Unadj.) Rs148.0535.6 27.6%  
Earnings per share (Unadj.) Rs19.115.9 119.7%  
Cash flow per share (Unadj.) Rs23.920.0 119.6%  
Dividends per share (Unadj.) Rs0.504.00 12.5%  
Dividend yield (eoy) %0.20.8 25.7%  
Book value per share (Unadj.) Rs128.9137.6 93.7%  
Shares outstanding (eoy) m84.827.77 1,091.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.0 176.3%   
Avg P/E ratio x13.633.3 40.7%  
P/CF ratio (eoy) x10.826.5 40.7%  
Price / Book Value ratio x2.03.9 52.0%  
Dividend payout %2.625.1 10.4%   
Avg Mkt Cap Rs m21,9514,127 531.8%   
No. of employees `0002.71.7 160.1%   
Total wages/salary Rs m1,841607 303.5%   
Avg. sales/employee Rs Th4,590.92,436.7 188.4%   
Avg. wages/employee Rs Th673.4355.2 189.6%   
Avg. net profit/employee Rs Th592.172.5 816.2%   
INCOME DATA
Net Sales Rs m12,5514,162 301.6%  
Other income Rs m54261 885.0%   
Total revenues Rs m13,0934,223 310.0%   
Gross profit Rs m2,055197 1,042.5%  
Depreciation Rs m41232 1,300.9%   
Interest Rs m9630 320.1%   
Profit before tax Rs m2,088197 1,061.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46973 644.4%   
Profit after tax Rs m1,619124 1,306.5%  
Gross profit margin %16.44.7 345.7%  
Effective tax rate %22.537.0 60.7%   
Net profit margin %12.93.0 433.2%  
BALANCE SHEET DATA
Current assets Rs m7,7781,629 477.5%   
Current liabilities Rs m4,3581,058 412.0%   
Net working cap to sales %27.213.7 198.6%  
Current ratio x1.81.5 115.9%  
Inventory Days Days5530 183.6%  
Debtors Days Days8034 238.2%  
Net fixed assets Rs m5,713556 1,026.9%   
Share capital Rs m17078 218.3%   
"Free" reserves Rs m10,547878 1,200.8%   
Net worth Rs m10,9371,069 1,022.8%   
Long term debt Rs m0159 0.0%   
Total assets Rs m15,5742,399 649.1%  
Interest coverage x22.87.6 301.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.81.7 46.5%   
Return on assets %11.06.4 171.7%  
Return on equity %14.811.6 127.7%  
Return on capital %20.018.5 108.2%  
Exports to sales %48.70.8 6,162.9%   
Imports to sales %7.11.4 505.4%   
Exports (fob) Rs m6,11533 18,586.3%   
Imports (cif) Rs m88958 1,524.4%   
Fx inflow Rs m6,16933 18,750.8%   
Fx outflow Rs m1,28563 2,033.7%   
Net fx Rs m4,884-30 -16,123.7%   
CASH FLOW
From Operations Rs m1,397127 1,103.2%  
From Investments Rs m-320-146 219.4%  
From Financial Activity Rs m-1,19622 -5,460.3%  
Net Cashflow Rs m-1023 -4,092.0%  

Share Holding

Indian Promoters % 55.4 65.4 84.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 3.7 91.6%  
FIIs % 3.9 5.2 75.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 25.8 143.4%  
Shareholders   30,437 12,723 239.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trims Losses; Rupee Devalues to Record Low(12:30 pm)

Stock markets in India trim losses to turn flat even as rupee fell 43 paise to hit record low of 70.29 against the US dollar.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 16, 2018 03:07 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS